{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:45:03Z","timestamp":1790721903476,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Accurate lymph node metastasis\u00a0(LNM) prediction is crucial for patients with advanced epithelial ovarian cancer (AEOC) since it guides the decisions about lymphadenectomy. Previous studies have shown that occult lymph node metastasis\u00a0(OLNM) is common in AEOC. The objective of our study is to quantitatively assess the probability of occult lymph node metastasis defined by\n                    <jats:sup>18<\/jats:sup>\n                    F-Fluorodeoxyglucose PET\/CT in AEOC and explore relationship between OLNM and PET metabolic parameters. The patients with pathologically confirmed AEOC who underwent PET\/CT for preoperative staging at our institute were reviewed. Univariate and multivariate analysis were performed to evaluate the predictive value of PET\/CT-related metabolic parameters for OLNM. The result of our study showed metastatic TLG index had a better diagnostic performance than other PET\/CT-related metabolic parameters. Two variables were independently and significantly associated with OLNM in multivariate analysis: metastatic TLG index and primary tumor location. The logistic model combining metastatic TLG index, primary tumor location, and CA125 might be a promising tool to effectively predict the individualized possibility of OLNM for AEOC patients.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-36640-0","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T11:03:34Z","timestamp":1686308614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Predictive value of PET metabolic parameters for occult lymph node metastases in PET\/CT defined node-negative patients with advanced epithelial ovarian cancer"],"prefix":"10.1038","volume":"13","author":[{"given":"Bing","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xihai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,9]]},"reference":[{"key":"36640_CR1","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4240\/wjgs.v6.i10.190","volume":"6","author":"S Akbulut","year":"2014","unstructured":"Akbulut, S. et al. Hydatid cyst of the pancreas: Report of an undiagnosed case of pancreatic hydatid cyst and brief literature review. World J. Gastrointest. Surg. 6, 190\u2013200. https:\/\/doi.org\/10.4240\/wjgs.v6.i10.190 (2014).","journal-title":"World J. Gastrointest. Surg."},{"key":"36640_CR2","doi-asserted-by":"publisher","first-page":"iv259","DOI":"10.1093\/annonc\/mdy157","volume":"29","author":"JA Ledermann","year":"2018","unstructured":"Ledermann, J. A. et al. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29, iv259. https:\/\/doi.org\/10.1093\/annonc\/mdy157 (2018).","journal-title":"Ann Oncol"},{"key":"36640_CR3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jogoh.2019.03.017","volume":"48","author":"V Lavoue","year":"2019","unstructured":"Lavoue, V. et al. Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Long text of the Joint French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa. Part 1: Diagnostic exploration and staging, surgery, perioperative care, and pathology. J. Gynecol. Obstet. Hum. Reprod. 48, 369\u2013378. https:\/\/doi.org\/10.1016\/j.jogoh.2019.03.017 (2019).","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"key":"36640_CR4","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.ygyno.2007.01.028","volume":"105","author":"A Pereira","year":"2007","unstructured":"Pereira, A., Magrina, J. F., Rey, V., Cortes, M. & Magtibay, P. M. Pelvic and aortic lymph node metastasis in epithelial ovarian cancer. Gynecol. Oncol. 105, 604\u2013608. https:\/\/doi.org\/10.1016\/j.ygyno.2007.01.028 (2007).","journal-title":"Gynecol. Oncol."},{"key":"36640_CR5","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1006\/gyno.1999.5370","volume":"74","author":"AJ Walter","year":"1999","unstructured":"Walter, A. J. & Magrina, J. F. Contralateral pelvic and aortic lymph node metastasis in clinical stage I epithelial ovarian cancer. Gynecol. Oncol. 74, 128\u2013129. https:\/\/doi.org\/10.1006\/gyno.1999.5370 (1999).","journal-title":"Gynecol. Oncol."},{"key":"36640_CR6","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1200\/JCO.2009.25.3617","volume":"28","author":"A du Bois","year":"2010","unstructured":"du Bois, A. et al. Potential role of lymphadenectomy in advanced ovarian cancer: A combined exploratory analysis of three prospectively randomized phase III multicenter trials. J. Clin. Oncol. 28, 1733\u20131739. https:\/\/doi.org\/10.1200\/JCO.2009.25.3617 (2010).","journal-title":"J. Clin. Oncol."},{"key":"36640_CR7","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1056\/NEJMoa1808424","volume":"380","author":"P Harter","year":"2019","unstructured":"Harter, P. et al. A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms. N. Engl. J. Med. 380, 822\u2013832. https:\/\/doi.org\/10.1056\/NEJMoa1808424 (2019).","journal-title":"N. Engl. J. Med."},{"key":"36640_CR8","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.7150\/jca.15644","volume":"7","author":"C Bachmann","year":"2016","unstructured":"Bachmann, C., Bachmann, R., Fend, F. & Wallwiener, D. Incidence and impact of lymph node metastases in advanced ovarian cancer: Implications for surgical treatment. J. Cancer 7, 2241\u20132246. https:\/\/doi.org\/10.7150\/jca.15644 (2016).","journal-title":"J. Cancer"},{"key":"36640_CR9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S1072-7515(03)00234-5","volume":"197","author":"P Morice","year":"2003","unstructured":"Morice, P. et al. Lymph node involvement in epithelial ovarian cancer: Analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. J. Am. Coll. Surg. 197, 198\u2013205. https:\/\/doi.org\/10.1016\/S1072-7515(03)00234-5 (2003).","journal-title":"J. Am. Coll. Surg."},{"key":"36640_CR10","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.ejrad.2011.01.112","volume":"81","author":"Y Yuan","year":"2012","unstructured":"Yuan, Y., Gu, Z. X., Tao, X. F. & Liu, S. Y. Computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography\/computer tomography for detection of metastatic lymph nodes in patients with ovarian cancer: A meta-analysis. Eur. J. Radiol. 81, 1002\u20131006. https:\/\/doi.org\/10.1016\/j.ejrad.2011.01.112 (2012).","journal-title":"Eur. J. Radiol."},{"key":"36640_CR11","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s00259-017-3638-z","volume":"44","author":"B Khiewvan","year":"2017","unstructured":"Khiewvan, B. et al. An update on the role of PET\/CT and PET\/MRI in ovarian cancer. Eur. J. Nucl. Med. Mol. Imaging 44, 1079\u20131091. https:\/\/doi.org\/10.1007\/s00259-017-3638-z (2017).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"36640_CR12","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s00259-015-3184-5","volume":"43","author":"F Caobelli","year":"2016","unstructured":"Caobelli, F. et al. Predictive value of (18)F-FDG PET\/CT in restaging patients affected by ovarian carcinoma: A multicentre study. Eur. J. Nucl. Med. Mol. Imaging 43, 404\u2013413. https:\/\/doi.org\/10.1007\/s00259-015-3184-5 (2016).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"36640_CR13","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1007\/s00259-015-3037-2","volume":"42","author":"K Kitajima","year":"2015","unstructured":"Kitajima, K. et al. Preoperative risk stratification using metabolic parameters of (18)F-FDG PET\/CT in patients with endometrial cancer. Eur. J. Nucl. Med. Mol. Imaging 42, 1268\u20131275. https:\/\/doi.org\/10.1007\/s00259-015-3037-2 (2015).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"36640_CR14","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1007\/s00259-022-05690-3","volume":"49","author":"J Deng","year":"2022","unstructured":"Deng, J. et al. Lung cancer with PET\/CT-defined occult nodal metastasis yields favourable prognosis and benefits from adjuvant therapy: A multicentre study. Eur. J. Nucl. Med. Mol. Imaging 49, 2414\u20132424. https:\/\/doi.org\/10.1007\/s00259-022-05690-3 (2022).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"36640_CR15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ygyno.2009.10.059","volume":"116","author":"EJ Nam","year":"2010","unstructured":"Nam, E. J. et al. Diagnosis and staging of primary ovarian cancer: Correlation between PET\/CT, Doppler US, and CT or MRI. Gynecol. Oncol. 116, 389\u2013394. https:\/\/doi.org\/10.1016\/j.ygyno.2009.10.059 (2010).","journal-title":"Gynecol. Oncol."},{"key":"36640_CR16","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1007\/s00259-008-0890-2","volume":"35","author":"K Kitajima","year":"2008","unstructured":"Kitajima, K. et al. Diagnostic accuracy of integrated FDG-PET\/contrast-enhanced CT in staging ovarian cancer: Comparison with enhanced CT. Eur. J. Nucl. Med. Mol. Imaging 35, 1912\u20131920. https:\/\/doi.org\/10.1007\/s00259-008-0890-2 (2008).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"36640_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2214\/ajr.182.1.1820227","volume":"182","author":"Y Yoshida","year":"2004","unstructured":"Yoshida, Y. et al. Incremental benefits of FDG positron emission tomography over CT alone for the preoperative staging of ovarian cancer. AJR Am. J. Roentgenol. 182, 227\u2013233. https:\/\/doi.org\/10.2214\/ajr.182.1.1820227 (2004).","journal-title":"AJR Am. J. Roentgenol."},{"key":"36640_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10040602","author":"A Tardieu","year":"2021","unstructured":"Tardieu, A. et al. Assessment of lymph node involvement with PET-CT in advanced epithelial ovarian cancer. A FRANCOGYN group study. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm10040602 (2021).","journal-title":"J. Clin. Med."},{"key":"36640_CR19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.ygyno.2013.08.022","volume":"131","author":"M Signorelli","year":"2013","unstructured":"Signorelli, M. et al. Detection of nodal metastases by 18F-FDG PET\/CT in apparent early stage ovarian cancer: A prospective study. Gynecol. Oncol. 131, 395\u2013399. https:\/\/doi.org\/10.1016\/j.ygyno.2013.08.022 (2013).","journal-title":"Gynecol. Oncol."},{"key":"36640_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ygyno.2012.04.023","volume":"126","author":"J Hynninen","year":"2012","unstructured":"Hynninen, J. et al. FDG PET\/CT in staging of advanced epithelial ovarian cancer: Frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread. Gynecol. Oncol. 126, 64\u201368. https:\/\/doi.org\/10.1016\/j.ygyno.2012.04.023 (2012).","journal-title":"Gynecol. Oncol."},{"key":"36640_CR21","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.3802\/jgo.2022.33.e28","volume":"33","author":"YS Chung","year":"2022","unstructured":"Chung, Y. S. et al. Prognostic value of complete metabolic response on (1)(8)F-FDG-PET\/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer. J. Gynecol. Oncol. 33, e28. https:\/\/doi.org\/10.3802\/jgo.2022.33.e28 (2022).","journal-title":"J. Gynecol. Oncol."},{"key":"36640_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11050713","author":"AM Perrone","year":"2019","unstructured":"Perrone, A. M. et al. Potential prognostic role of (18)F-FDG PET\/CT in invasive epithelial ovarian cancer relapse. A preliminary study. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers11050713 (2019).","journal-title":"Cancers (Basel)"},{"key":"36640_CR23","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s12149-018-1289-1","volume":"32","author":"S Han","year":"2018","unstructured":"Han, S., Kim, H., Kim, Y. J., Suh, C. H. & Woo, S. Prognostic value of volume-based metabolic parameters of (18)F-FDG PET\/CT in ovarian cancer: A systematic review and meta-analysis. Ann. Nucl. Med. 32, 669\u2013677. https:\/\/doi.org\/10.1007\/s12149-018-1289-1 (2018).","journal-title":"Ann. Nucl. Med."},{"key":"36640_CR24","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1245\/s10434-011-2153-x","volume":"19","author":"HH Chung","year":"2012","unstructured":"Chung, H. H. et al. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis in patients with epithelial ovarian cancer. Ann. Surg. Oncol. 19, 1966\u20131972. https:\/\/doi.org\/10.1245\/s10434-011-2153-x (2012).","journal-title":"Ann. Surg. Oncol."},{"key":"36640_CR25","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1007\/s00259-014-2803-x","volume":"41","author":"JW Lee","year":"2014","unstructured":"Lee, J. W. et al. The role of metabolic tumor volume and total lesion glycolysis on (1)(8)F-FDG PET\/CT in the prognosis of epithelial ovarian cancer. Eur. J. Nucl. Med. Mol. Imaging 41, 1898\u20131906. https:\/\/doi.org\/10.1007\/s00259-014-2803-x (2014).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"36640_CR26","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet, P. & Sugarbaker, P. H. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat. Res. 82, 359\u2013374. https:\/\/doi.org\/10.1007\/978-1-4613-1247-5_23 (1996).","journal-title":"Cancer Treat. Res."},{"key":"36640_CR27","doi-asserted-by":"publisher","first-page":"e0258783","DOI":"10.1371\/journal.pone.0258783","volume":"16","author":"C Mimoun","year":"2021","unstructured":"Mimoun, C. et al. Using a new diagnostic tool to predict lymph node metastasis in advanced epithelial ovarian cancer leads to simple lymphadenectomy decision rules: A multicentre study from the FRANCOGYN group. PLoS ONE 16, e0258783. https:\/\/doi.org\/10.1371\/journal.pone.0258783 (2021).","journal-title":"PLoS ONE"},{"key":"36640_CR28","doi-asserted-by":"publisher","first-page":"102464","DOI":"10.1016\/j.jogoh.2022.102464","volume":"51","author":"A Crestani","year":"2022","unstructured":"Crestani, A. et al. A pre-operative radiological score to predict lymph node metastasis in advanced epithelial ovarian cancer. J. Gynecol. Obstet. Hum. Reprod. 51, 102464. https:\/\/doi.org\/10.1016\/j.jogoh.2022.102464 (2022).","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"key":"36640_CR29","doi-asserted-by":"publisher","first-page":"9646846","DOI":"10.1155\/2022\/9646846","volume":"2022","author":"H Yao","year":"2022","unstructured":"Yao, H. & Zhang, X. Prediction model of residual neural network for pathological confirmed lymph node metastasis of ovarian cancer. Biomed. Res. Int. 2022, 9646846. https:\/\/doi.org\/10.1155\/2022\/9646846 (2022).","journal-title":"Biomed. Res. Int."},{"key":"36640_CR30","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1093\/jjco\/hyi109","volume":"35","author":"N Oriuchi","year":"2005","unstructured":"Oriuchi, N. et al. A new, accurate and conventional five-point method for quantitative evaluation of ascites using plain computed tomography in cancer patients. Jpn. J. Clin. Oncol. 35, 386\u2013390. https:\/\/doi.org\/10.1093\/jjco\/hyi109 (2005).","journal-title":"Jpn. J. Clin. Oncol."},{"key":"36640_CR31","doi-asserted-by":"publisher","first-page":"638124","DOI":"10.3389\/fonc.2021.638124","volume":"11","author":"X Wang","year":"2021","unstructured":"Wang, X. & Lu, Z. Radiomics analysis of PET and CT components of (18)F-FDG PET\/CT imaging for prediction of progression-free survival in advanced high-grade serous ovarian cancer. Front. Oncol. 11, 638124. https:\/\/doi.org\/10.3389\/fonc.2021.638124 (2021).","journal-title":"Front. Oncol."},{"key":"36640_CR32","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1118\/1.4948679","volume":"43","author":"RR Beichel","year":"2016","unstructured":"Beichel, R. R. et al. Semiautomated segmentation of head and neck cancers in 18F-FDG PET scans: A just-enough-interaction approach. Med. Phys. 43, 2948\u20132964. https:\/\/doi.org\/10.1118\/1.4948679 (2016).","journal-title":"Med. Phys."},{"key":"36640_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.6004\/jnccn.2021.0007","volume":"19","author":"DK Armstrong","year":"2021","unstructured":"Armstrong, D. K. et al. Ovarian cancer, version 2.2020, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Cancer Netw. 19, 191\u2013226. https:\/\/doi.org\/10.6004\/jnccn.2021.0007 (2021).","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"36640_CR34","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/aogs.12322","volume":"93","author":"O Svolgaard","year":"2014","unstructured":"Svolgaard, O. et al. Lymphadenectomy in surgical stage I epithelial ovarian cancer. Acta Obstet. Gynecol. Scand. 93, 256\u2013260. https:\/\/doi.org\/10.1111\/aogs.12322 (2014).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"36640_CR35","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1053\/j.semnuclmed.2014.06.005","volume":"44","author":"P Grant","year":"2014","unstructured":"Grant, P., Sakellis, C. & Jacene, H. A. Gynecologic oncologic imaging with PET\/CT. Semin. Nucl. Med. 44, 461\u2013478. https:\/\/doi.org\/10.1053\/j.semnuclmed.2014.06.005 (2014).","journal-title":"Semin. Nucl. Med."},{"key":"36640_CR36","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s00330-008-1271-8","volume":"19","author":"K Kitajima","year":"2009","unstructured":"Kitajima, K., Murakami, K., Yamasaki, E., Kaji, Y. & Sugimura, K. Accuracy of integrated FDG-PET\/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer. Eur. Radiol. 19, 1529\u20131536. https:\/\/doi.org\/10.1007\/s00330-008-1271-8 (2009).","journal-title":"Eur. Radiol."},{"key":"36640_CR37","doi-asserted-by":"publisher","first-page":"711648","DOI":"10.3389\/fonc.2021.711648","volume":"11","author":"HZ Chen","year":"2021","unstructured":"Chen, H. Z. et al. The development and validation of a CT-based radiomics nomogram to preoperatively predict lymph node metastasis in high-grade serous ovarian cancer. Front. Oncol. 11, 711648. https:\/\/doi.org\/10.3389\/fonc.2021.711648 (2021).","journal-title":"Front. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36640-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36640-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36640-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T11:08:52Z","timestamp":1686308932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36640-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,9]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["36640"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-36640-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2693892\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,9]]},"assertion":[{"value":"15 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9439"}}